Population pharmacokinetic modeling of PF-06439535 (a bevacizumab biosimilar) and reference bevacizumab (Avastin (R)) in patients with advanced non-squamous non-small cell lung cancer

Li, CSW; Sweeney, K; Cronenberger, C

Sweeney, K (corresponding author), Pfizer Inc, Clin Pharmacol Pharmacometr, Pfizer Global Prod Dev, Eastern Point Rd, Groton, CT 06340 USA.

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020; 85 (3): 487

Abstract

Purpose The objectives of this analysis were to characterize the population pharmacokinetics (PK) of PF-06439535 (a bevacizumab biosimilar) and refere......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索